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Objective: To evaluate autonomic and cardiovascular function, as well as inflammatory
and oxidative stress markers in ob/ob female mice.
Methods: Metabolic parameters, cardiac function, arterial pressure (AP), autonomic,
hormonal, inflammatory, and oxidative stressmarkers were evaluated in 12-weeks female
wild-type (WT group) and ob/ob mice (OB group).
Results: OB animals showed increased body weight, blood glucose, and triglyceride
levels, along with glucose intolerance, when compared to WT animals. Ejection fraction
(EF) and AP were similar between groups; however, the OB group presented diastolic
dysfunction, as well as an impairment on myocardial performance index. Moreover,
the OB group exhibited important autonomic dysfunction and baroreflex sensitivity
impairment, when compared to WT group. OB group showed increased Angiotensin
II levels in heart and renal tissues; decreased adiponectin and increased inflammatory
markers in adipose tissue and spleen. Additionally, OB mice presented a higher damage
to proteins and lipoperoxidation and lower activity of antioxidant enzymes in kidney and
heart. Correlations were found between autonomic dysfunction with angiotensin II and
inflammatory mediators, as well as between inflammation and oxidative stress.
Conclusions: Our results showed that female adult ob/ob mice presented discrete
diastolic dysfunction accompanied by autonomic disorder, which is associated with
inflammation and oxidative stress in these animals.
Keywords: obesity, cardiac dysfunction, autonomic, inflammation, female
INTRODUCTION
It is now well-established that both type 2 diabetes mellitus (DM) and obesity result from a
combination of genetic factors and lifestyle (James, 1995; Must et al., 1999). It should be noted
that the incidence of cardiovascular disease (CVD) in diabetic individuals with one risk factor
is equivalent to the risk of a non-diabetic individual with the association of three risk factors
(Abraham, 2003).
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Similarly to observed in men, CVD is the major cause of
mortality in women, especially after menopause (Go et al., 2014).
It is important to note that DM substantially increases mortality
risk (Kannel et al., 1976; Kaseta et al., 1999). Recently, an elegant
study from Italy, showed that diabetes increased the risk of first
ever ischemic stroke by more than 50% in both men and women
(Policardo et al., 2015). Interestingly, postmenopausal women
at the age of 55–74 years presented a higher risk for ischemic
stroke thanmen of comparable age. Indeed, females have a higher
risk of developing cardiovascular complication due to diabetes
than male. Impairment on endothelial response due to diabetes is
more evident in women than in males, which alters the positive
hemodynamic estrogen effects by complex interactions between
insulin and estrogen signaling. Hyperglycemia unfavorably alters
the balance of expression and activity of estrogen receptors
(Dantas et al., 2012). Furthermore, an increased oxidative
stress and endothelin-1 can be observed, which contribute to
promoting vasoconstriction and platelet aggregation (Cardillo
et al., 2002) and decreases endothelium-dependent relaxation
and NO production via impaired insulin signaling (Dantas et al.,
2012). Additionally, diabetic females present higher susceptibility
to diabetic cardiopathology as well as CHD. Kiencke et al. (2010)
showed that preclinical diabetic cardiomyopathy was common
in diabetic patients, with female sex being the only independent
predictor of LV hypertrophy. However, our knowledge of CVD
and its mechanisms is largely based on studies involving male
individuals. Therefore, it is essential to establish strategies for the
treatment of CVD in women in order to reduce the morbidity
and mortality rates among them.
The association between bioactive molecules released from
adipose tissue and oxidative stress may be responsible, at
least in part, for insulin resistance and endothelial dysfunction
(Janszky et al., 2004). In this sense, in recent years, the
immune system (mainly related to increase of pro-inflammatory
cytokine levels) has been the focus of several studies on the
development and prognosis of coronary artery disease and
CVD risk (Ridker et al., 2000a,b; Pradhan et al., 2002; Janszky
et al., 2004). However, the mechanisms underlying the impact
of female gender on autonomic dysfunction, inflammation and
oxidative stress associated with end organ damage induced by
obesity/diabetes are still unknown.
A model of type 2 diabetes that has been widely studied is
the ob/ob mice (leptin deficiency), as their morbid obesity and
type 2 diabetes are similar to those seen in humans (Coleman,
1978). The ob/ob mice present obesity, hyperglycemia, insulin
resistance, diabetic neuropathy (Hasty et al., 2001; Drel et al.,
2006), as well as decreased baroreflex sensitivity (Hilzendeger
et al., 2010). Therefore, since the association between diabetes
and obesity considerably increases the risk of CVD and most
studies with CVD have been restricted to male subjects, more
research involving female individuals should be carried out.
Thus, the aim of this study was to evaluate cardiovascular
function, autonomic modulation, inflammatory and oxidative
stress markers in ob/ob female mice. We tested the hypothesis
that ob/ob female mice present an impairment on cardiovascular
and autonomic parameters, as well as an increased oxidative
stress and inflammatory markers when compared to the wild
type, and that this model of diabetes and obesity could be
used for further studies regarding cardiovascular changes in this
condition. Thus, this work is justified by the lack of exploratory
mechanistic studies in female ob/ob mice.
MATERIALS AND METHODS
Twelve-week-old female wild-type C57Bl6/J and leptin-deficient
C57Bl6/J ob/obmice were obtained from the Animals Facilities of
the Federal University of Sao Paulo. The mice were divided into
wild-type group (WT; n= 14) and ob/ob group (OB; n= 14). All
surgical procedures and protocols were approved by the ethics
committee of the Universidade Nove de Julho (AN0021/2014)
and were conducted in accordance with the Guide for the
Care and Use of Laboratory Animals, issued by the National
Institutes of Health. All in vivo evaluations and euthanasia were
conducted on non-ovulatory phase of estrous cycle, once it is
well-documented in the literature that the different phases of
estrous cycle, as well as the ovarian hormone deprivation may
lead to significant adjustments on cardiovascular physiology in
females (Saleh et al., 2000; Flues et al., 2010; Kuo et al., 2010). The
tissues were harvested 24 h after the hemodynamicmeasurement.
Metabolic Evaluations
Blood glucose, triglyceride, and cholesterol concentrations were
measured (Accucheck and Accutrend, Roche), after 4-h fasting.
For glucose tolerance test (GTT), mice were fasted, with
animals receiving only water, for 6 h. Blood samples were
taken from a tail cut at 0, 15, 30, 60, and 90min after i.p.
glucose load (1.5 g/kg). Blood glucose was determined by Accu-
Chek Advantage Blood Glucose Monitor (Roche Diagnostic
Corporation, Indianapolis, IN).
Echocardiographic Evaluation
Echocardiography was performed by an observer blinded to the
groups, according to the Guidelines of the American Society of
Echocardiography. Mice were anesthetized (ketamine–xylazine
80:40mg/kg i.p.), and images were obtained using a Sequoia 512
ultrasound system (ACUSON, Mountain View, CA, USA) with
a 10–14 MHz linear transducer for the measurement systolic
function [ejection fraction (EF) and fractional shortening (FS)]
and diastolic function [left ventricular isovolumetric relaxation
time (IVRT) and E wave/A wave ratio (E/A)] and global cardiac
function [myocardial performance index (MPI)] (Wichi et al.,
2007).
Hemodynamic Measurements
One day after echocardiographic evaluation, mice were
anesthetized (ketamine–xylazine 80:40mg/kg i.p.) and
polyethylene-tipped Tygon cannulas (4 cm of PE-08 connected
to 2 cm of PE-50, Clay Adams) filled with heparinized saline
were inserted into the carotid artery and jugular vein for direct
measurements of arterial pressure (AP) and drug administration,
respectively. Twenty-four hours after the cannulation procedure,
the arterial cannula was connected to a transducer (Blood
Pressure XDCR, Kent© Scientific), and blood pressure signals
were recorded for a 20-min period using a microcomputer
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equipped with an analog-to-digital converter (CODAS, 4-kHz
sampling frequency, Dataq Instruments), being the animals
conscious, under no anesthesia effect. The recorded data were
analyzed on a beat-to-beat basis to quantify changes in AP and
heart rate (HR) (Heeren et al., 2009).
Baroreflex sensitivity was evaluated by a mean index
relating the tachycardic or the bradycardic responses to mean
AP changes (∼30–40mmHg), induced by increasing doses
of sodium nitroprusside (100–250 ng/kg body weight i.v.)
and phenylephrine (80–250 ng/kg body weight i.v.) injections,
respectively, being the animals conscious, under no anesthesia
effect, right after the hemodynamic recording (Heeren et al.,
2009).
Autonomic Modulation
Linear Analyses
Time-domain analysis consisted in calculating mean pulse
interval (PI) variance from its respective time series. For
frequency domain analysis, the whole 20-min time series of
PI and systolic arterial pressure (SAP) were cubic-spline-
interpolated and decimated to be equally spaced in time.
Following linear trend removal, power spectral density was
obtained by the Fast Fourier Transformation. Spectral power
for low- (LF: 0.1–1.0Hz), and high- (HF: 1.0–5.0Hz) frequency
bands was calculated by means of power spectrum density
integration within each frequency bandwidth, using a customized
routine (MATLAB 6.0, Mathworks) (Heeren et al., 2009).
Non-linear Analyses
Poincaré plot analysis
The Poincaré plot is a graph in which each R-R interval is plotted
as a function of the previous R-R interval. Briefly, scattergrams
of successive R-R intervals were plotted for the entire period, and
the SD of instantaneous R-R interval variability and the SD of
continuous variability (SD2) were then analyzed. The SD1 is an
index of the instantaneous recording of the variability of beat-
to-beat and represents the parasympathetic activity, whereas the
SD2 index represents the long-term HRV and reflects the overall
variability (Raimundo et al., 2013).
Detrended Fluctuation Analysis
The detrended fluctuation analysis technique was used to
quantify the fractal scaling properties of short- and intermediate-
term R-R interval time series. The root-mean-square fluctuation
of integrated and detrended time series is measured at different
observation windows and plotted against the size of the
observation window on a log-log scale. The details of this method
have been described elsewhere (Lombardi et al., 1996).
Approximate Entropy and Sample Entropy
Approximate entropy (ApEn) was proposed by Pincus in 1991
as a method for measuring regularity and complexity in time
series, and has been successfully used to analyze physiological
time series (Pincus, 1991). The sample entropy (SampEn) was
used to assess the complexity of the HR “signal” under the
different conditions. SampEn measures the likelihood that runs
of patterns that are close to each other will remain close in the
next incremental comparisons (Pincus, 1991).
Angiotensin II and Angiotensin 1–7
Evaluations
Angiotensin levels were analyzed by a high-performance liquid
chromatography (HPLC). The heart, kidney, and adipose tissues
were homogenized with 100mM sodium phosphate buffer,
340mm sucrose, and 300mM NaCl at pH 7.2. The samples were
concentrated on C18Sep-Pak column, activated with methanol
(5mL), tetrahydrofuran (5ml), hexane (5mL), methanol (5mL),
and water (10mL), as previously described (Ronchi et al., 2007).
Determination of Inflammatory Mediators
Interleukin-1 (IL-6), plasminogen activator inhibitor-1 (PAI-1),
tumor necrosis factor-α (TNF-α), and adiponectin levels in the
adipose tissue and spleen were determined using a commercially
available ELISA kit (R&D Systems Inc.), in accordance with
the manufacturer’s instructions. ELISA was performed in 96-
well polystyrene microplates with a specific monoclonal antibody
coating. Absorbance was measured at 540 nm in a microplate
reader (da Palma et al., 2016).
Oxidative Stress Profile Assessment
The heart (ventricles) and kidney were cut into small pieces,
placed in ice-cold buffer, and homogenized in an ultra-Turrax
blender with 1 g tissue per 5mL 150mM KCl and 20 nM sodium
phosphate buffer, pH 7.4. The homogenate was centrifuged at
600 g for 10min at −26◦C. All procedures were described in
detail elsewhere (da Palma et al., 2016).
Briefly, analysis followed the protocols:
Lipoperoxidation evaluated by thiobarbituric acid reactive
substances (TBARS): For the TBARS assay, trichloroacetic
acid (10%, w/v) was added to the homogenate to precipitate
proteins and to acidify the samples. This mixture was then
centrifuged (10,000 g, 3min), the protein-free sample was
extracted, and thiobarbituric acid (0.67%, w/v) was added
to the reaction medium. The tubes were placed in a water
bath (100◦C) for 15min. The absorbencies were measured at
535 nm using a spectrophotometer.
Determination of protein oxidation using the protein
carbonyl assay: Tissue samples were incubated with
2,4-dinitrophenylhydrazine (DNPH 10mM) in a 2.5M
HCl solution for 1 h at room temperature in the dark.
Samples were vortexed every 15min. Subsequently, a 20%
trichloroacetic acid (w/v) solution was added and the solution
was incubated on ice for 10 min and centrifuged for 5 min
at 1,000 g to collect protein precipitates. An additional wash
was performed with 10% trichloroacetic acid (w/v). The
pellet was washed three times with ethanolethyl acetate (1:1)
(v/v). The final precipitates were dissolved in 6 M guanidine
hydrochloride solution and incubated for 10 min at 37◦C, and
the absorbance was measured at 360 nm.
Antioxidant enzyme activities: The quantification of SOD
activity, expressed as U/mg protein, was based on the
inhibition of the reaction between O2
·− and pyrogallol. CAT
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activity was determined by measuring the decrease inH2O2
absorbance at 240 nm.
Statistical Analysis
Data are expressed as mean ± SEM. The normality of data
was tested by Kolmogorov–Smirnov. Student t-test was used to
compare groups. Pearson correlation was used to analyze the
association between variables. For the correlation analysis, it was
used between 5 and 7 animals per group. The significance level
was established at P ≤ 0.05.
RESULTS
Metabolic and Echocardiographic
Evaluations
At the end of the protocol, body weight, abdominal adipose
tissue, glycemia, triglycerides, and GTT were higher in the OB
group than in the WT group. No differences were observed
regarding total cholesterol between the groups (Table 1).
TABLE 1 | Body weight, tissues weight, and metabolic evaluations in wild type
group (WT; n = 14) and ob/ob group (OB; n = 14).
WT OB
Body weight (g) 20.1 ± 0.2 50.2 ± 0.5*
Abdominal adipose tissue (g) 0.41 ± 0.01 8.02 ± 0.20*
Glycaemia (mmol/L) 6.71 ± 0.33 9.99 ± 0.55*
Tryglicerydes (mg/dL) 107 ± 13 142 ± 6*
Cholesterol (mg/dL) 162 ± 2 167 ± 3
GTT (mg/dL/min) 15, 424 ± 3, 351 38, 491 ± 1, 272*
Data are reported as mean± SEM. *p < 0.05 vs. WT.
FIGURE 1 | Cardiac function in WT (n = 14) and OB (n = 14). (A) Ejection
fraction (EF); (B) isovolumetric relaxation time (IVRT); (C) myocardium
performance index (MPI) groups. *p < 0.05 vs. WT.
Echocardiographic examinations showed that WT and OB
groups presented similar systolic function, since that no
difference was observed in EF (Figure 1A) and FS (WT: 30
± 1 vs. OB: 32 ± 1%) parameters. However, the OB mice
presented increased values of IVRT when compared to WT mice
(Figure 1B), despite the values of E/A ratio were similar between
the groups (WT: 1.81 ± 0.13 vs. OB: 1.44 ± 0.06). The global
cardiac function, evaluated by the myocardial performance index
(an index of cardiac stress), demonstrated increased values in OB
group when compared to WT group (Figure 1C).
Hemodynamic and Autonomic
Assessments
There were no differences in the direct hemodynamic
measurements between the groups regarding the systolic,
diastolic, and mean APs as well as HR (Table 2). Baroreflex
sensitivity, evaluated for both tachycardic responses and
bradycardic responses was impaired in the OB group when
compared to the WT group (Figure 2A).
Regarding HR variability, there was a decrease in RMSSD
index, LF and HF bands in OB group when compared to the
WT group (Table 2). The OB group exhibited a reduction of PI
variance (VAR-IP) and LF/HF ratio when compared to the WT
group (Figures 2B,C).
TABLE 2 | Hemodynamic and autonomic parameters in wild type group (WT; n =
8) and ob/ob group (OB; n = 8).
WT OB
HEMODYNAMIC PARAMETERS
SAP (mmHg) 132 ± 2 129 ± 4
DAP (mmHg) 96 ± 2 97 ± 3
MAP (mmHg) 114 ± 2 114 ± 4
HR (bpm) 562 ± 14 564 ± 20
HEART RATE VARIABILITY
RMSSD (ms) 12.0 ± 1.3 6.1 ± 0.9*
LF (ms2) 135 ± 26 7 ± 2*
HF (ms2) 43 ± 6 13 ± 2*
ARTERIAL PRESSURE VARIABILITY
VAR (mmHg2) 20 ± 3 24 ± 3
LF (mmHg2) 9 ± 1 10 ± 1
BAROREFLEX SENSITIVITY
Alpha index (ms/mmHg) 3.12 ± 0.32 0.74 ± 0.07*
NON-LINEAR ANALYSES
SD1 13.9 ± 2.5 6.0 ± 1.3*
SD2 24.2 ± 1.5 15.0 ± 2.3*
Alpha 1 1.00 ± 0.09 0.57 ± 0.05*
Alpha 2 0.65 ± 0.04 0.95 ± 0.03*
SampEn 1.56 ± 0.09 1.72 ± 0.03
ApEn 1.41 ± 0.05 1.47 ± 0.02
Data are reported as mean± SEM. *p< 0.05 vs. WT. SAP, systolic arterial pressure; DAP,
diastolic arterial pressure; MAP, mean arterial pressure; HR, heart rate; RMSSD, root mean
square of the successive differences; VAR, total variance; LF, low-frequency band; (0.1–
1.0 Hz); HF, high-frequency band (HF: 1.0–5 Hz); Poincare plot (SD1 and SD2); Detrended
fluctuation analysis (Alpha 1 and Alpha 2); Sample entropy (SampEn), and Approximate
entropy (ApEn).
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FIGURE 2 | Cardiovascular autonomic assessment in WT (n = 8) and OB (n = 8) groups. (A) baroreflex sensitivity evaluated by bradycardic and tachycardic
responses to arterial pressure changes; (B) total variance of the pulse interval; (C) sympathovagal balance. *p < 0.05 vs. WT.
There were no differences between the groups regarding
variability in systolic blood pressure (SAP-VAR). Additionally,
the LF band of systolic blood pressure (SAP-LF) was similar
in both WT and OB groups (Table 2). Moreover, spontaneous
baroreflex sensitivity, evaluated by alpha index, was reduced in
OB group when compared to WT group (Table 2), confirming
the results obtained from tachycardic and bradycardic responses.
When evaluated autonomic modulation by non-linear
analyses, SD1, SD2, and Alpha 1 parameters were reduced, while
Alpha 2 was increased in OB animals as compared with WT
(Table 2).
Determination of Angiotensin II and 1–7
Levels
There were no differences regarding the levels of angiotensin
II (Figure 3A), and angiotensin 1–7 between the WT and OB
groups in the adipose tissue. Regarding angiotensin dosed in
the kidney, a decrease in angiotensin 1–7 in the OB group was
observed when compared to the WT group. In addition, there
was an increase in angiotensin II in theOB groupwhen compared
to WT group (Figure 3B).
In the left ventricle, the OB group showed an increase in
angiotensin 1–7 when compared to theWT group. Moreover, the
OB group presented an increase in angiotensin II when compared
to the WT group (Figure 3C).
Evaluation of Inflammatory and Hormonal
Markers
The OB group showed lower adiponectin values when compared
to theWT group in the adipose tissue (Figure 4A). Regarding IL-
6, no differences in adipose tissue were found between the studied
groups. We observed an increase in PAI-1 in the OB group when
compared to the WT group (Table 3).
Adiponectin in the spleen was lower in the OB group when
compared to the WT group (Figure 4B). We observed an
increase in TNF-alpha in the OB group spleen tissue when
compared to the WT group. Furthermore, the OB group had
elevated levels of IL-6 in the spleen, as well as an increased
PAI-1 levels in the OB group when compared to the WT group
(Table 3).
Oxidative Stress Investigation
Regarding renal oxidative stress, protein oxidation (carbonyls)
was increased in the OB group when compared to theWT group.
Additionally, lipoperoxidation (TBARS) was higher in the OB
group when compared to theWT group. There was no difference
in SOD between the WT and OB groups. The OB group
showed a reduction in CAT when compared to the WT group
(Table 4).
Cardiac protein oxidation and lipoperoxidation were
increased in the OB group when compared to the WT group.
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FIGURE 3 | Angiotensin II levels in WT (n = 6) and OB (n = 6) groups. (A) adipose tissue; (B) kidney; (C) heart. *p < 0.05 vs. WT.
There were no differences between groups in cardiac levels of the
antioxidant enzymes SOD and CAT (Table 4).
Correlation Analysis
Positive correlations were found between baroreflex sensitivity
and inflammatory mediators/or hormonal markers: tachycardic
(r=−0.81) and bradycardic responses (r= 0.75) were correlated
with IL-6 in spleen tissue; the alpha index was positively
correlated with adiponectin in the spleen tissue (r = 0.57) and
was inversely correlated with PAI-1 in the spleen tissue (r= 0.65)
andwith angiotensin 2 in the left ventricle (r=−0.58) (Figure 5).
Moreover, indexes of cardiac autonomic modulation were
associated with hormonal, inflammatory and oxidative stress
markers: RMSSD was positively correlated with adiponectin (r
= 0.86) and was negatively correlated with spleen levels of PAI-1
(r=−0.81) and cardiac levels of angiotensin II (r=−0.68); VAR
PI was inversely correlated with cardiac levels of angiotensin II
(r = −0.72); %LF was inversely correlated with cardiac levels of
angiotensin 1–7 (r = −0.68); and %HF was positively correlated
with cardiac levels of angiotensin 1–7 (r = 0.68) (Figure 5).
Spleen levels of TNF-alpha were negatively correlated with
angiotensin 1–7 in cardiac (r = −0.75) and renal tissues (r =
−0.76) and were positively correlated with angiotensin II levels
in renal tissue (r = 0.92) and cardiac lipoperoxidation (r = 0.64).
The spleen levels of PAI-1 were also directly correlated with
cardiac protein oxidation (r = 0.60) and lipoperoxidation (r =
0.64) as well as with renal lipoperoxidation (r = 0.84).
Considering only the OB group, it was observed a positive
correlation between RMSSD and adiponectin (r = 0.89) and a
negative correlation between RMSSD and PAI-1 (r = −0.67)
Figure 5.
DISCUSSION
Results of this study showed marked metabolic dysfunction in
female obese diabetic mice. In addition, cardiac dysfunctions,
impaired baroreflex sensitivity, and HRV, as well as increased
inflammatory profile and oxidative stress markers were displayed
by OB group as compared with WT group.
The ob/ob mice are characterized by hyperphagia caused
by the absence of leptin (Coleman, 1978; Zhang et al., 1994)
accompanied by an increase in a fat deposition (Coleman,
1978; Verploegen et al., 1997). In our research, a significant
increase in body weight, blood glucose, and glucose intolerance.
FIGURE 4 | Adiponectin levels in WT (n = 6) and OB (n = 6) groups. (A)
Adipose tissue; (B) spleen. *p < 0.05 vs. WT.
TABLE 3 | Inflammatory markers in abdominal adipose tissue and spleen in wild
type group (WT; n = 6) and ob/ob group (OB; n = 6).
WT OB
ABDOMINAL ADIPOSE TISSUE
IL-6 (pg/ml) 154 ± 7 141 ± 16
PAI-1 (pg/ml) 1, 353 ± 211 4, 616 ± 710*
SPLEEN
TNF alpha (pg/ml) 70 ± 5 96 ± 4*
IL-6 (pg/ml) 148 ± 15 380 ± 52*
PAI-1 (pg/ml) 1, 577 ± 407 3, 706 ± 723*
Data are reported as mean ± SEM. *p < 0.05 vs. WT.
The increase in body weight, besides being associated with
metabolic negative changes, directly affects cardiac structure, and
function in women (Kannel et al., 1976; Kaseta et al., 1999).
Concerning echocardiographic evaluations, although systolic
function was similar between experimental groups, an increased
IVRT and an impairment in myocardial performance index
were observed in ob/ob female mice. Thus, it is possible that,
at this age, the animals are beginning to develop left ventricle
diastolic dysfunction, since that only IVRT was changed. Left
ventricular diastolic dysfunction reflects an impairment of the
filling properties of the left ventricle, being associated with the
future development of heart failure in different populations
(Bella et al., 2002). An increase of body mass index (Russo
et al., 2011), as well as reduced glucose tolerance (Shimabukuro
et al., 2011) were associated with worse left ventricle diastolic
function, independent of ventricle mass and associated risk
factors.
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In fact, diabetes appears to attenuate the possible
cardioprotective effects of ovarian hormones. Regarding the
mechanisms associated with ventricular dysfunction, comparing
males and females db/db mice, Bowden et al. (2015) revealed
that diabetes-induced upregulation of both hypertrophic and
pro-oxidant gene expression in females. Additionally, changes
in insulin signaling, oxidative stress, mitochondrial dysfunction,
inflammatory status, renin angiotensin system, cardiac glycogen
metabolism (Reichelt et al., 2013), and myocardial calcium
handling (Regitz-Zagrosek et al., 2010) can be pointed out as
potential mechanisms associated with diabetic females cardiac
dysfunction.
In order to expand our knowledge, we investigate if the
diastolic dysfunction in ob/ob female mice was associated with
cardiovascular autonomic modulation. Regarding this issue,
the OB group demonstrated important signals of autonomic
TABLE 4 | Renal and cardiac oxidative stress in wild type group (WT; n = 8) and
ob/ob group (OB; n = 8).
WT OB
RENAL
Protein oxidation (nmol/mg protein) 4.8 ± 0.7 6.4 ± 0.5*
Lipoperoxidation (µmoles/mg protein) 8.8 ± 1.2 11.0 ± 0.8*
SOD (USOD/mg protein) 19 ± 1 18 ± 1
CAT (nmol/mg protein) 3.5 ± 0.3 2.4 ± 0.2*
CARDIAC
Protein oxidation (nmol/mg protein) 3.2 ± 0.2 4.3 ± 0.4*
Lipoperoxidation (µmoles/mg protein) 4.3 ± 0.6 5.7 ± 0.3*
SOD (USOD/mg protein) 10 ± 1 10 ± 1
CAT (nmol/mg protein) 0.3 ± 0.02 0.3 ± 0.03
Data are reported as mean± SEM. *p < 0.05 vs. WT.
dysfunction, as observed by reduction of RMSSD, HF, and LF
bands of PI variability. These autonomic changes were possibly
associated with the impairment of baroreflex sensitivity observed
in this group, being a permissive element to the establishment
of primary changes in autonomic modulation in males rats
(Irigoyen et al., 1995).
The imbalance between sympathetic and parasympathetic
modulation may also be associated with renin-angiotensin
system stimulation, leading to the AT1 receptor activation
(Campagnaro et al., 2012). Indeed, in our study, although we
did not find any significant AP differences between WT and OB
groups, obese animals showed a decrease in baroreflex sensitivity
accompanied by with an increase in angiotensin II levels in the
heart and in the kidney. Thus, our findings suggest an increased
activation of the constrictor axis of the system may be related to
increased risk of disorders of autonomic modulation. In fact, our
results demonstrated inverse correlations between RMSSD, VAR
IP, and alpha index with angiotensin II levels in the cardiac tissue.
Moreover, it is plausible to consider that the hyperglycemia
altering negatively the balance of expression and activity of
estrogen receptors (Dantas et al., 2012), which hold a positive role
against the deleterious effects of angiotensin II (Xue et al., 2007),
may be contributing to the elevated levels of angiotensin II and
reduced levels of angiotensin 1–7 in the kidney of OB group when
compared to theWT group. Similar changes in angiotensin II and
angiotensin 1–7 levels have been associated with the development
of different diseases (Campagnaro et al., 2012), and contributing
to the cardiovascular and autonomic dysfunction (Dzau and Re,
1994; Silva et al., 2015; Srinivasa et al., 2015). It is interesting to
note that, in the left ventricle, OB mice presented an increase in
angiotensin II, as well as in angiotensin 1–7 levels, suggesting
a possible counter-regulatory mechanism in order to maintain
cardiac homeostasis. The angiotensin II/ACE/AT1 receptor axis
activation leads to vasoconstriction of arterioles, resulting in
FIGURE 5 | Correlations between: (A) Alpha Index and cardiac Ang II; (B) VAR-IP and cardiac Ang II; (C) %HF and cardiac Ang 1–7; (D) %LF and cardiac Ang 1–7;
(E) RMSSD and PAI-1; (F) RMSSD and Adiponectin. It was used between 5 and 7 animals per group. The correlations E and F were made using only the OB group.
Open circles represent the WT group and closed circles represent the OB group.
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decreased blood flow, whichmay affect glomerular filtration. This
impairment in glomerular filtration may increase the production
of inflammatory cytokines and reactive oxygen species, leading to
increased oxidative stress (Silva et al., 2015).
It is important to emphasize that some studies have shown
that the vagal nerve canmodulate the inflammatory and oxidative
stress responses in some pathophysiological situations (Van Gaal
et al., 2006). In the present study, we chose to assess the
inflammatory status in spleen and adipose tissue, since that are
important regulators of neuro-immune-endocrine function (Van
Gaal et al., 2006; Lau, 2010). A decrease in adiponectin (adipose
tissue and spleen) and an increase in TNF-alpha (spleen), IL-6
(spleen), and PAI-1 (adipose tissue, spleen) in the OB animals
were observed, showing an inflammatory status in this group.
These changes may negatively influence glucose homeostasis and
lipid profile, AP, clotting, and fibrinolysis, which may lead to
endothelial dysfunction, and atherosclerosis (Tapsell et al., 2004).
Adiponectin exerts beneficial effects in type 2 diabetic patients
since it is related to increased insulin sensitivity in a variety
of tissues (Tapsell et al., 2004). In contrast, IL-6 and PAI-1 are
directly related to diabetes mellitus. IL-6 for example, stimulates
the inhibition of insulin action, leading to increased glucose
(Hotamisligil et al., 1994; Fernandez-Real and Ricart, 2003).
Moreover, IL-6 interferes with the anti-inflammatory effect of
insulin and may also cause inhibition of the insulin signal
transduction (Hotamisligil et al., 1994; Kajitani et al., 2010).
The action of IL-6 may be considered a “two-way street,” since
high levels of IL-6 may be regarded as an insulin resistance
predictor of endothelial function and hence may be involved in
the development of type 2 diabetes (Juhan-Vague et al., 1991).
In turn, the PAI-1 has been associated with increased
insulin concentrations and decreased insulin sensitivity (Juhan-
Vague et al., 1991). Furthermore, Juhan-Vague et al. (1991)
suggested that increased PAI-1 concentrations may be the
connection between insulin resistance and coronary disease.
Thus, our findings pointing to increased glucose, triglycerides,
and glucose intolerance observed in the OB group may be
related to decreased adiponectin and increased IL-6, TNF-
alpha, and PAI-1. Importantly, we observed negative correlations
between baroreflex sensitivity and spleen PAI-1 and IL-6 levels
and between RMSSD and PAI-1 in spleen tissue. Moreover,
spontaneous baroreflex and RMSSD were positively correlated
with adiponectin.
In addition to an increased inflammatory profile in the obese
animals, we observed, in the heart and kidneys, a decrease
in antioxidant capacity and an increase in membrane lesion,
as demonstrated by increased lipoperoxidation (TBARS) and
protein oxidation (carbonyls). The induced oxidative damage
in cells and tissues has been linked to the etiology of various
degenerative diseases such as heart disease, atherosclerosis, and
pulmonary disorders (Ames et al., 1993). It is also worth
mentioning that there was a decrease in CAT in OB animals,
suggesting an impairment of redox balance in obese animals.
Additionally, in the present study, we observed that the higher
levels of inflammatorymediators (PAI-1 and TNF-alpha in spleen
tissue) were correlated with higher levels of protein oxidation
(cardiac tissue) and lipoperoxidation (renal and cardiac tissues).
Beside the negative effects of hyperglycemia on estrogen
activity and expression, which could other possible explanation.
Our study has limitations that deserve comments. We
have methodological limitations regarding cardiac function
measurements, since that we not confirmed echocardiographic
parameters by direct left ventricular catheterization, tissue
Doppler, or magnetic resonance imaging. Although we observed
important relationships between metabolic, inflammatory, and
autonomic parameters, a cause-effect relationship cannot be
established. Regarding the model, the ob/ob mice present a
nonsense mutation (C to T) in codon 105 changes an Arg residue
to a stop codon causing premature truncation, rendering the
translated protein biologically inactive. Although there are high
levels of leptin mRNA in adipocytes, the animals completely
lack functional leptin (Friedman et al., 1991; Zhang et al., 1994).
Despite the ob/ob show similar type 2 diabetes complication
as seen human, as obesity, hyperglycemia, insulin resistance,
diabetic neuropathy, as well as decreased baroreflex sensitivity,
the etiology of these complications are different in human and
ob/ob mice. It is important to emphasize that we used young
animals instead aged animals, which could mimic more the
human situation. However, our intention was to show the effects
of the obesity and diabetes in females, avoiding the possible
effects of the aging. It is worth to consider that in the last two
decades, type 2 diabetes, once thought to be a metabolic disorder
exclusively of adulthood, has become increasingly more frequent
in obese adolescents (Pinhas-Hamiel and Zeitler, 2005).
CONCLUSIONS
In conclusion, our results show that adult female ob/ob mice
presented diastolic dysfunction associated with cardiovascular
autonomic impairment, which may have triggered inflammation
and oxidative stress. These findings may shed some light on the
mechanisms involved in the diastolic dysfunction development
promoted by the association of diabetes and obesity in the
female gender, which has conjectured a higher risk of developing
cardiovascular complication in females when compared to males.
It is likely a consequence of a greater impairment on endothelial
response due to diabetes in females, which promotes an alteration
on insulin and estrogen signaling (reducing the benefits of the
estrogen on the cardiovascular system), leading to an increased
oxidative stress and inflammation as observed in this study.
Additionally, anti-obesity and anti-inflammatory therapeutic
interventions, as weight loss and exercise training as well as
new approaches considering the physiological particularities of
the female sex should be considered in the management of the
metabolic disorders also in adult female subjects in which the
protective action of hormones are still present.
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